This study aims to develop and standardize a user-friendly Ayurvedic device called the Dhuma Yantra for delivering (Dhuma Nasya), and to efficacy of Dhuma Nasya with Prototype, Navan Nasya, and classical Dhuma Nasya in the management of Ardhavabhedaka (Migraine)

Development And Validation Of Dhuma Yantra And Its Comparative Clinical Evaluation With Navan Nasya And Dhuma Nasya With Classical Method In Ardhavabhedaka (Migraine): A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093745

Enrollment

Registered

2025-08-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a) Age : between 17 to 70 years b) Gender: both c) Socio-economic status: all d) Willing to participate in the study. e) Patients with the classical picture of ARDHAVBHEDAKA [Migraine] will be selected irrespective of Sex, Religion, and Profession.

Exclusion criteria

Exclusion criteria: (1) Patients who were not eligible for NASYA as per Ayurvedic Texts. (2) Age less than 16 years and greater than 70 years. (3) Referred pain in one half of the head due to disorders of the Eye, Ear, Nose, Throat, Teeth, etc., was excluded (4) Patient having Familial Hemiplegic Migraine (FHM), Complicated Migraine, etc. (5) Patient suffering from uncontrolled Diabetes, Tuberculosis, Hypertension, Malignancy, and/or any other General Debilitating Health condition. (6) Patient who needed surgical intervention (Polyp, etc.)

Design outcomes

Primary

Measure	Time frame
The improvement in patients will be assessed on the basis of relief in the signs and symptoms of the disease. For this purpose main signs and symptoms were given score according to their severity.Timepoint: (DAY 0),(DAY 15),(DAY 45)	—

Secondary

Measure	Time frame
Improvement in MSQ: MIGRAINE SPECIFIC QUALITY OF LIFE QUESTIONNAIRE and VAS(visual analogue scale).Timepoint: (DAY 0),(DAY 15),(DAY 45)	—

Countries

India

Contacts

Public ContactDr Santosh Kumar Bhatted

All India Institute of Ayurveda

santoshbhatted@rediffmail.com9414048459

Outcome results